Procurement Summary
Country: Brazil
Summary: Acquisition of Orlistate 120 Mg Capsule, Potassium Citrate 10 Meq (1080 Mg) Tablet, Dimenihdrinate+Vit B6+Glyc+Fruit (3+5+100+100)Mg/Ml Amp 10 Ml, Vitamined Zinc Oxide Ointment Tub 45 G, Tacr...
Deadline: 06 Jul 2026
Posting Date: 25 Jun 2026
Other Information
Notice Type: Tender
TOT Ref.No.: 143951499
Document Ref. No.: 90448/2026
Competition: ICB
Financier: Self Financed
Purchaser Ownership: Public
Tender Value: Refer Document
Purchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_details
Login to see detailsTender Details
Object: Electronic Auction - Acquisition of ORLISTATE 120 MG CAPSULE, POTASSIUM CITRATE 10 MEQ (1080 MG) TABLET, DIMENYHDRINATE+VIT B6+GLYC+FRUIT (3+5+100+100)MG/ML AMP 10 ML, VITAMINED ZINC OXIDE OINTMENT TUB 45 G, TACROLIMO 0.03% OINTMENT TUB 10 G, TESTOSTERONE (CYPIONATE) 100 MG/ML SOL INJECTABLE AMPOULE 2 ML, HYDROCORTISONE (SODIUM SUCCINATE) 100 MG POWDER SUN INJ FA, MYCOPHENOLATE (SODIUM) 180 MG COATED TABLET, GOLIMUMAB 50 MG/0.5 ML SOL INJ PRE-FILLED SYRINGE 0.5 ML, OMALIZUMABE 150 MG POWDER TO UASG Code: 92301 Notice from: 06/24/2026 from 08:00 to 17:59 Proposal Delivery: from 06/24/2026 at 08:00 ORLISTATE, DOSAGE 120 MG Quantity: 318220 POTASSIUM CITRATE, CONCENTRATION 10 MEQ, PHARMACEUTICAL FORM ABSORPTION DELAYED Quantity: 567846 DIMENIHDRINATE, PRESENTATION ASSOCIATED WITH PYRIDOXINE + GLUCOSE + FRUCTOSE, DOSAGE 3MG + 5MG + 100MG + 100MG/ML, INJECTABLE SOLUTION MEDICATION TYPE Quantity: 32928 RETINOL, COMPOSITION ASSOCIATED WITH CHOLECALCIFEROL AND ZINC, CONCENTRATION 5, 000UI + 900UI + 150MG/G, PHARMACEUTICAL FORM OINTMENT Quantity: 38384 TACROLIMO, DOSAGE 0.3 MG/G, PHARMACEUTICAL OINTMENT FORM Quantity: 7206 TESTOSTERONE, COMPOSITION CYPIONATE SALT, CONCENTRATION 100 MG/ML, PHARMACEUTICAL FORM SOLUTION INJECTABLE Quantity: 2244 HYDROCORTISONE, COMPOSITION SODIUM SUCCINATE SALT, CONCENTRATION 100 MG, PHARMACEUTICAL FORM LYOPHIL POWDER FOR INJECTION Quantity: 70774 MYCOPHENOLATE, SODIUM COMPOSITION, CONCENTRATION 180 MG Quantity: 27848 GOLIMUMAB, CONCENTRATION 50 MG, PHARMACEUTICAL FORM INJECTABLE SOLUTION, ADDITIONAL CHARACTERISTICS IN FILLED SYRINGE Quantity: 120 OMALIZUMAB, CONCENTRATION 150 MG, INJECTABLE PHARMACEUTICAL FORM Quantity: 216 SUGAMADEX, SODIUM SALT COMPOSITION, CONCENTRATION 100 MG/ML, FORM PHARMACEUTICAL INJECTABLE SOLUTION Quantity: 22450
Documents
Tender Notice